Bendamustine Hydrochloride Injection, Solution — FDA Drug Shortage
The FDA lists a drug shortage record for Bendamustine Hydrochloride Injection, Solution (injection) from Cephalon, LLC (a wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.) with status To Be Discontinued. The shortage was first posted on 07/23/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Cephalon, LLC (a wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.)
- Package NDC
- 63459-390-08
- Dosage Form
- Injection
- Presentation
- Treanda, Injection, Solution, 25 mg/5 mL, 1 vial, Single-Dose in 1 carton (NDC 63459-390-08)
- Initial Posting
- 07/23/2026
- Revised Date